Literature DB >> 3894232

Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2.

D Vismara, G Lombardi, E Piccolella, V Colizzi.   

Abstract

The relationship between the production of interleukin-1 (IL-1) and interleukin-2 (IL-2) after stimulation of human mononuclear cells within an antigenic extract from Candida albicans was analyzed in both responder and nonresponder donors. Culture supernatants from responders contained both IL-1 and IL-2 activity, whereas the supernatants from nonresponders contained only IL-1 and no appreciable IL-2. However, the addition of exogenous IL-2 to nonresponder cultures restored the normal proliferative response. Similar observations were made when cells from mice infected intravenously with high doses of Mycobacterium bovis BCG were cultured; these cells showed a marked impairment of the proliferative response to purified protein derivative. Spleen cells from BCG-induced unresponsive mice failed to produce IL-2 despite the fact that normal IL-1 activity was present in the culture. Again, the addition of exogenous IL-2 fully reversed the proliferative unresponsiveness. Thus, the presence of IL-1 does not necessarily induce production of IL-2, and the proliferative unresponsiveness is therefore due to a primary lack of IL-2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894232      PMCID: PMC262014          DOI: 10.1128/iai.49.2.298-304.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice.

Authors:  H Wagner; C Hardt; K Heeg; M Röllinghoff; K Pfizenmaier
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

Review 2.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

3.  Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation.

Authors:  G Lombardi; E Piccolella; D Vismara; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans.

Authors:  E Piccolella; G Lombardi; R Morelli
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis.

Authors:  M L Thoman; W O Weigle
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Human lymphocyte proliferation. II. Formation of activated (G1) cells.

Authors:  F Bettens; F Kristensen; C Walker; A L de Weck
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

7.  Human interleukin 1: purification and properties.

Authors:  L B Lachman
Journal:  Fed Proc       Date:  1983-06

8.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Mitogenic response of human peripheral blood lymphocytes to a purified C. albicans polysaccharide fraction: lack of helper activities is responsible for the in vitro unresponsiveness to a second antigenic challenge.

Authors:  E Piccolella; G Lombardi; R Morelli
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

View more
  8 in total

1.  Limiting dilution analysis of T cell unresponsiveness to mycobacteria in advanced disseminated tuberculosis.

Authors:  M S Gilardini Montani; F Del Gallo; G Lombardi; P Del Porto; E Piccolella; F Arienzo; V Colizzi
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

2.  Identification of a 35-kilodalton Mycobacterium tuberculosis protein containing B- and T-cell epitopes.

Authors:  D Vismara; M F Mezzopreti; M S Gilardini Montani; M S Gilardini; P Del Porto; G Lombardi; E Piccolella; G Damiani; R Rappuoli; V Colizzi
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.

Authors:  I Müller; S P Cobbold; H Waldmann; S H Kaufmann
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

4.  Recombinant human interleukin-2 reverses in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients.

Authors:  H Shiratsuchi; Y Okuda; I Tsuyuguchi
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 5.  The role of T cell--macrophage interactions in tuberculosis.

Authors:  S H Kaufmann; I E Flesch
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Effects of dexamethasone on human natural killer cell cytotoxicity, interferon production, and interleukin-2 receptor expression induced by microbial antigens.

Authors:  E Piccolella; G Lombardi; D Vismara; F Del Gallo; V Colizzi; A Dolei; F Dianzani
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

7.  Regulation of immune interferon production during the response to soluble microbial antigens.

Authors:  E Piccolella; A Dolei; G Lombardi; D Vismara; P Pizzoli; V Colizzi; F Dianzani
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Hsa-let-7c controls the committed differentiation of IGF-1-treated mesenchymal stem cells derived from dental pulps by targeting IGF-1R via the MAPK pathways.

Authors:  Gen-Xia Liu; Shu Ma; Yao Li; Yan Yu; Yi-Xiang Zhou; Ya-Die Lu; Lin Jin; Zi-Lu Wang; Jin-Hua Yu
Journal:  Exp Mol Med       Date:  2018-04-13       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.